155 related articles for article (PubMed ID: 35044579)
1. Synthesis and in vitro evaluation of antitumor activity of spiro[indolo[2,1-b]quinazoline-pyrano[2,3-d]pyrimidine] and spiro[indolo[2,1-b]quinazoline-pyrido[2,3-d]pyrimidine] derivatives by using 2D and 3D cell culture models.
Sadeghian Z; Bayat M; Safari F
Mol Divers; 2022 Dec; 26(6):3173-3184. PubMed ID: 35044579
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides bearing additional solubilizing functions.
Smaill JB; Rewcastle GW; Loo JA; Greis KD; Chan OH; Reyner EL; Lipka E; Showalter HD; Vincent PW; Elliott WL; Denny WA
J Med Chem; 2000 Apr; 43(7):1380-97. PubMed ID: 10753475
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine and quinazoline derivatives as potent antitumor agents.
Hu H; Dong Y; Li M; Wang R; Zhang X; Gong P; Zhao Y
Bioorg Chem; 2019 Sep; 90():103086. PubMed ID: 31280016
[TBL] [Abstract][Full Text] [Related]
4. Substituted thiazoles V. synthesis and antitumor activity of novel thiazolo[2,3-b]quinazoline and pyrido[4,3-d]thiazolo[3,2-a]pyrimidine analogues.
Al-Omary FA; Hassan GS; El-Messery SM; El-Subbagh HI
Eur J Med Chem; 2012 Jan; 47(1):65-72. PubMed ID: 22056277
[TBL] [Abstract][Full Text] [Related]
5. Facile Multicomponent Synthesis, Computational, and Docking Studies of Spiroindoloquinazoline Compounds.
Palapetta SC; Gurusamy H; Krishnan S; Ponnusamy S
ACS Omega; 2022 Mar; 7(9):7874-7884. PubMed ID: 35284703
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido[2,3-d]pyrimidine derivatives targeting epidermal growth factor receptor.
Hou J; Wan S; Wang G; Zhang T; Li Z; Tian Y; Yu Y; Wu X; Zhang J
Eur J Med Chem; 2016 Aug; 118():276-89. PubMed ID: 27132165
[TBL] [Abstract][Full Text] [Related]
7. A Sulfonic Acid Polyvinyl Pyridinium Ionic Liquid Catalyzes the Multi-Component Synthesis of Spiro-indoline-3,5'-pyrano[2,3-
Khalaj M; Taherkhani M; Payen L; Klein A
Molecules; 2023 Apr; 28(9):. PubMed ID: 37175073
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine kinase inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(phenylamino)pyrido[d]pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor.
Smaill JB; Palmer BD; Rewcastle GW; Denny WA; McNamara DJ; Dobrusin EM; Bridges AJ; Zhou H; Showalter HD; Winters RT; Leopold WR; Fry DW; Nelson JM; Slintak V; Elliot WL; Roberts BJ; Vincent PW; Patmore SJ
J Med Chem; 1999 May; 42(10):1803-15. PubMed ID: 10346932
[TBL] [Abstract][Full Text] [Related]
9. Novel one-pot, three-component synthesis of spiro[indoline-pyrazolo[4',3':5,6]pyrido[2,3-d]pyrimidine]trione library.
Ghahremanzadeh R; Sayyafi M; Ahadi S; Bazgir A
J Comb Chem; 2009; 11(3):393-6. PubMed ID: 19425616
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of Some Spiro Indeno[1,2-
Mohammadi Ziarani G; Asadi S; Badiei A; Sharifi A; Amanlou M
Iran J Pharm Res; 2016; 15(Suppl):55-63. PubMed ID: 28228804
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Antioxidant Activity Evaluation of Some Novel Aminocarbonitrile Derivatives Incorporating Carbohydrate Moieties.
Khajeh Dangolani S; Panahi F; Tavaf Z; Nourisefat M; Yousefi R; Khalafi-Nezhad A
ACS Omega; 2018 Aug; 3(8):10341-10350. PubMed ID: 31459162
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Neurotropic Activity and Molecular Docking Study of New Derivatives of pyrano[4″,3″:4',5']pyrido[3',2':4,5]thieno[3,2-
Dashyan SS; Babaev EV; Paronikyan EG; Ayvazyan AG; Paronikyan RG; Hunanyan LS
Molecules; 2022 May; 27(11):. PubMed ID: 35684318
[TBL] [Abstract][Full Text] [Related]
13.
Keshari AK; Singh AK; Raj V; Rai A; Trivedi P; Ghosh B; Kumar U; Rawat A; Kumar D; Saha S
Drug Des Devel Ther; 2017; 11():1623-1642. PubMed ID: 28615927
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, molecular docking and in silico ADMET profile of pyrano[2,3-d]pyrimidine derivatives as antimicrobial and anticancer agents.
Abd El-Sattar NEA; El-Adl K; El-Hashash MA; Salama SA; Elhady MM
Bioorg Chem; 2021 Oct; 115():105186. PubMed ID: 34314914
[TBL] [Abstract][Full Text] [Related]
15. Analysis of quinazoline and pyrido[2,3-d]pyrimidine N9-C10 reversed-bridge antifolates in complex with NADP+ and Pneumocystis carinii dihydrofolate reductase.
Cody V; Galitsky N; Luft JR; Pangborn W; Queener SF; Gangjee A
Acta Crystallogr D Biol Crystallogr; 2002 Sep; 58(Pt 9):1393-9. PubMed ID: 12198294
[TBL] [Abstract][Full Text] [Related]
16. New C2- and N3-Modified Thieno[2,3-d]Pyrimidine Conjugates with Cytotoxicity in the Nanomolar Range.
Mavrova AT; Dimov S; Yancheva D; Rangelov M; Wesselinova D; Naydenova E
Anticancer Agents Med Chem; 2022; 22(6):1201-1212. PubMed ID: 34315388
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, biological evaluation and molecular docking study of 1,2,3-1H-triazoles having 4H-pyrano[2,3-d]pyrimidine as potential Mycobacterium tuberculosis protein tyrosine phosphatase B inhibitors.
Thanh ND; Hai DS; Ha NTT; Tung DT; Le CT; Van HTK; Toan VN; Toan DN; Dang LH
Bioorg Med Chem Lett; 2019 Jan; 29(2):164-171. PubMed ID: 30551903
[TBL] [Abstract][Full Text] [Related]
18. Sulfur and selenium derivatives of quinazoline and pyrido[2,3-d]pyrimidine: synthesis and study of their potential cytotoxic activity in vitro.
Moreno E; Plano D; Lamberto I; Font M; Encío I; Palop JA; Sanmartín C
Eur J Med Chem; 2012 Jan; 47(1):283-98. PubMed ID: 22104973
[TBL] [Abstract][Full Text] [Related]
19. Design, facile synthesis, and evaluation of novel spiro- and pyrazolo[1,5-c]quinazolines as cholinesterase inhibitors: Molecular docking and MM/GBSA studies.
Gálvez J; Polo S; Insuasty B; Gutiérrez M; Cáceres D; Alzate-Morales JH; De-la-Torre P; Quiroga J
Comput Biol Chem; 2018 Jun; 74():218-229. PubMed ID: 29655025
[TBL] [Abstract][Full Text] [Related]
20. Analysis of stereoelectronic properties, mechanism of action and pharmacophore of synthetic indolo[2,1-b]quinazoline-6,12-dione derivatives in relation to antileishmanial activity using quantum chemical, cyclic voltammetry and 3-D-QSAR CATALYST procedures.
Bhattacharjee AK; Skanchy DJ; Jennings B; Hudson TH; Brendle JJ; Werbovetz KA
Bioorg Med Chem; 2002 Jun; 10(6):1979-89. PubMed ID: 11937358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
